Active site plasticity revealed from the structure of the enterobacterial N-ribohydrolase RihA bound to a competitive inhibitor by Garau, Gianpiero et al.
Garau et al. BMC Structural Biology 2010, 10:14
http://www.biomedcentral.com/1472-6807/10/14
Open Access RESEARCH ARTICLE
© 2010 Garau et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research article Active site plasticity revealed from the structure of 
the enterobacterial N-ribohydrolase RihA bound to 
a competitive inhibitor
Gianpiero Garau1,2, Laura Muzzolini1, Paola Tornaghi1 and Massimo Degano*1
Abstract
Background: Pyrimidine-preferring N-ribohydrolases (CU-NHs) are a class of Ca2+-dependent enzymes that catalyze 
the hydrolytic cleavage of the N-glycosidic bond in pyrimidine nucleosides. With the exception of few selected 
organisms, their physiological relevance in prokaryotes and eukaryotes is yet under investigation.
Results: Here, we report the first crystal structure of a CU-NH bound to a competitive inhibitor, the complex between 
the Escherichia coli enzyme RihA bound to 3, 4-diaminophenyl-iminoribitol (DAPIR) to a resolution of 2.1 Å. The ligand 
can bind at the active site in two distinct orientations, and the stabilization of two flexible active site regions is pivotal 
to establish the interactions required for substrate discrimination and catalysis.
Conclusions: A comparison with the product-bound RihA structure allows a rationalization of the structural 
rearrangements required for an enzymatic catalytic cycle, highlighting a substrate-assisted cooperative motion, and 
suggesting a yet overlooked role of the conserved His82 residue in modulating product release. Differences in the 
structural features of the active sites in the two homologous CU-NHs RihA and RihB from E. coli provide a rationale for 
their fine differences in substrate specificity. These new findings hint at a possible role of CU-NHs in the breakdown of 
modified nucleosides derived from RNA molecules.
Background
Pyrimidine-preferring nucleoside hydrolases (CU-NHs)
are members of the broad family of Ca2+-dependent
hydrolases that catalyze the cleavage of the N-glycosidic
bond in nucleosides [1,2]. Enzymes with NH activity have
been isolated from several different organisms, ranging
from bacteria to fungi, nematodes, insects, and plants [3-
7]. The biological function of these enzymes in both
prokaryotes and eukaryotes is still controversial, and the
widespread presence of NH-encoding genes can either be
ascribed to a conserved role in general nucleotide catabo-
lism. For instance, several purine or pyrimidine-aux-
otrophic parasites such as protozoa rely on nucleoside
hydrolases to recycle nitrogenous bases uptaken from the
host, lacking nucleoside phosphorylase activity [7]. In
addition, NHs are also apparently involved in species-
specific processes. Purine-specific NHs appear to modu-
late sporulation in spore-forming bacteria, such as Bacil-
lus cereus and Bacillus anthracis [5], or to promote host
anaesthesia during micropredation by blood-sucking
insects such as Aedes aegypti [8]. In the yeast Saccharo-
myces cerevisiae, the URH1 uridine hydrolase displays a
highly selective pyridine nucleosidase activity towards
nicotinamide riboside that is instrumental for NRK1-
independent NAD+ synthesis [9,10].
In Escherichia coli nucleoside phosphorylases catalyze
the scission of the N-glycosidic bond in the most com-
mon RNA nucleosides. The presence of two enzymes
with CU-NH activity has been proposed to provide con-
siderable flexibility for mRNA degradation in different
environmental conditions, or the ability to hydrolyze
some low-level modified nucleoside of tRNA and rRNA
[3,11]. Indeed, the enterobacterial RihB CU-NH is active
on synthetic 5-substituted uridines, and thus may also act
on similarly modified nucleosides found in RNA mole-
cules. More than one hundred naturally-occurring modi-
fications have been so far observed in RNA nucleosides,
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playing important roles in the structural stability and
function of RNA in all kingdoms of life [12,13]. However,
RNA modifications can be introduced also by exogenous
alkylating agents [14] or associated to antibiotic sensitiv-
ity [15], which alter the integrity and function of cellular
RNAs (i.e. ribosome trapping and formation of truncated
proteins). Despite the fact that nucleotide modification
processes and effects have been the subject of intense
research during last years, the catabolic pathways of
modified nucleosides still requires investigation. A
tempting possibility is that CU-NHs may provide a pri-
mary degradation pathway for such modified nucleic
acids components. Hence, further insights into the sub-
strate specificity of bacterial CU-NH, together with the
definition of the structural determinants involved in sub-
strate binding, are required to validate this hypothesis.
CU-NHs are homologous to the non-specific IU-NH
isozymes at central active site positions, and thus can be
classified as belonging to a common homology group,
termed NH Group I [11]. A recent mutagenesis study
demonstrated that the absence of two specific active site
tyrosines in CU-NHs is responsible for the slow turnover
of purine nucleosides [16]. Two CU-NH-encoding genes
are present in E. coli cells, termed either ybeK and yeiK, or
rihA and rihB, respectively. The rihB gene was shown as
physiologically silent, but its transcription is raised 25-
fold in autoinducer-2 conditioned medium [17]. The rihA
gene is poorly expressed only in glucose-rich medium
[3,17]. The gene products RihA and RihB have been char-
acterized using steady-state kinetics and X-ray crystallog-
raphy, and display similar kinetic constants, characterized
by mid- to high-micromolar KM values for uridine and
cytidine [16,18,19]. RihB can also hydrolyze the N-glyco-
sidic bond in 5-substituted uridines, reinforcing the
hypothesis of a broad substrate specificity to include
modified RNA nucleosides. The crystal structure of RihB
has been determined both in presence of the fortuitous
ligand glycerol [11], and of the slowly-hydrolyzed purinic
substrate inosine [16], while RihA was co-crystallized
with the reaction product ribose [19]. These structures
remarked the overall similarity with IU-NHs in both the
protein fold and ribosyl binding site. The ribose-bound
RihA displays an open structure suggesting that a ligand
mimicking the nitrogenous base is required for enzyme
closure. In particular, two active site loops connecting
strand β3 to helix α3 (loop αL) and the C-terminal por-
tion of helix α9 were highly flexible and not traceable in
electron density maps. A single histidine residue (His13)
was observed in two discrete orientations, and the transi-
tion between these two conformations was postulated as
crucial in allowing the rearrangement between the open
and closed forms. Yet, the nature of the interactions stabi-
lizing the closed form structure, and the events following
chemistry that lead to the active site opening remain
largely unknown.
Here, we report the crystal structure of the complex
between the E. coli RihA enzyme and the competitive
inhibitor 3,4-diamino phenyliminoribitol (DAPIR) to a
resolution of 2.1 Å. The compound resembles the geo-
metric and electronic features of the transition state of
the reaction catalyzed by the homologous IU-NH from C.
fasciculata. Binding of the ligand to the active site of
RihA results in the rearrangement of the αL and α9 seg-
ments through an induced fit mechanism that allows the
interaction of the enzyme with the nitrogenous base-
mimicking moiety of the ligand. Interestingly, the resi-
dues involved in interactions with the nitrogenous base
differ between the highly homologous CU-NHs RihA and
RihB from E. coli, suggesting that comparable levels of
transition state stabilization for the hydrolysis of pyrimi-
dine nucleosides can be achieved through qualitatively
different interactions. A comparison with the structure of
the reaction product-bound RihA provides snapshots of
the enzyme structure during pyrimidine nucleoside
hydrolysis, and identifies the central interactions that
drive the transition from the open to the closed confor-
mation. The structure of the complex underscores the
adaptability of the NH active site, showing how the active
site of RihA can adapt to different ligands and accommo-
date several modified nitrogenous bases, and thus sup-
porting the hypothesis of a role of CU-NHs extending to
the catabolism of modified RNA nucleosides.
Results
Structure of the RihA-DAPIR complex
The requirement of a detailed description of the NH-sub-
strate contacts for the design of antiprotozoan com-
pounds has prompted both experimental and theoretical
studies [16,20-26]. The purpose of this work was the
characterization a CU-NH enzyme bound to a competi-
tive inhibitor in order to gain further insights into the
specificity of pyrimidine-preferring NHs. The RihA
enzyme is a good candidate for such structural analysis
since it has been characterized in complex with the prod-
uct of the hydrolytic reaction [19], and can thus yield
detailed information on the relevant steps of the CU-NH
catalytic cycle. We identified the compound 3,4-diamino
phenyliminoribitol (DAPIR, Fig. 1) as a competitive
inhibitor of RihA, with a KI = 85 ± 7 μM. RihA was co-
crystallized bound to DAPIR, and the structure of the
complex was determined at a resolution of 2.1 Å (Table
1). 1'-substituted iminoribitols are tight-binding, compet-
itive inhibitors of several NH enzymes. The DAPIR mole-
cule structurally resembles pyrimidine nucleosides, albeit
lacking the O2 carbonyl that has been postulated as
essential for catalysis [19]. Imiboribitols also mimic the
transition state structure of the reaction catalyzed by theGarau et al. BMC Structural Biology 2010, 10:14
http://www.biomedcentral.com/1472-6807/10/14
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Table 1: Crystallographic data
Data collection
Resolution range (Å) 37.5-2.1 2.21-2.1
Number of observed reflections 232,754 31,773
Number of unique reflections 68,457 9,929
Completeness (%) 97.2 95.4
Multiplicity 3.4 3.2
Mean I/σ(I) 8.1 3.0
Rsym 0.122 0.388
Refinement
Resolution range (Å) 37.50-2.1 2.15-2.1
Number of reflections (F > 0) 65,238 4,760
Rcrys 0.203 0.254
Rfree 0.241 0.304
rmsd bonds (Å) 0.020
rmsd angles (°) 1.689
Mean B factor (Å2) 30.3
Model quality
Residues in favored regions of Ramachandran plot (%) 97.8
Residues outliers in Ramachandran plot (%) 0.5
Unusual rotamers (%) 0.9
Data collection and refinement statistics for the RihA-DAPIR complex.
Rsym = ￿hkl￿i||Ii(hkl)|-|<I(hkl)||>|/￿hkl￿i|Ii(hkl)|, where Ii(hkl) is the ith measurement of reflection hkl, and <I(hkl)> is the average value from the 
individual measurements
Rcrys = ￿hkl||Fo(hkl)|-|Fc(hkl)||/￿hkl|Fo(hkl)|, where Fo(hkl) and Fc(hkl) are the measured and calculated structure factor of reflection hkl, 
respectively
Rfree, same as Rcrys, but calculated on a subset of randomly-selected reflection excluded from all stages refinement (3,455 total, 265 in the 
highest resolution shell).Garau et al. BMC Structural Biology 2010, 10:14
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IU-NH enzyme from C. fasciculata [27]. The molecular
replacement method unambiguously identified four inde-
pendent molecules in the asymmetric unit, arranged as a
tetramer with the subunits related by 222 symmetry. The
final model comprises the four RihA polypeptides, and
due to flexibility residues 225 through 229 in chain A, 76
to 85 and 225 to 230 in chain B, 76 to 85 and 223 to 229 in
chain C, and 77 to 84 in chain D were omitted. These
amino acids belong to the αL loop and α9 helix, that were
disordered in the RihA-ribose complex. Residues Gly38
in all chains (as in other NH enzymes), Gly89 and Phe223
of chain B (both highly flexible) are outside the 99.8%
regions of the Ramachandran plot.
The structure of each monomer maintains the α/β fold
that is typical of NHs, with the Ca2+-containing active
site located in a deep, narrow cavity at the C-terminal end
of a core 10-stranded β-sheet surrounded by α-helices
(Fig. 2A). The functional tetramer is identical within
experimental error to that observed in the RihA-ribose
orthorhombic crystals (rmsd = 0.61 Å considering 1,208
Cα atoms), thus showing that the binding of different
ligands does not induce significant changes in the quater-
nary structure (Fig. 2B). Furthermore, the interface area
between two dimer subunits remains unaltered when
comparing the ribose-bound and the DAPIR-bound com-
plexes. The only relevant difference occurring at the
dimer interface involves the C-terminal portion of helix
α9 of one subunit and the turn connecting the strands
β11 and β12 of the proximal one. The side chain of
Trp232 rotates slightly around its side chain torsion angle
χ1 (from -52° to -76°) to establish a π-π stacking interac-
tion with the aromatic ring of Tyr279 from the second
subunit. Moreover, Lys231 is at H-bond distance with the
carbonyl groups of Tyr279 and Tyr280. These interac-
tions are present in each subunit, and therefore provide
significant stabilization to the RihA quaternary structure
when a ligand is bound at the active site.
Binding of a competitive inhibitor to the RihA CU-NH
The electron density map showed the presence of one
inhibitor molecule in each of the monomers in the crystal
asymmetric unit. The αL loop of RihA undergoes a tight-
ening around the inhibitor only in chain A, while the α9
helix is completely traceable in electron density maps in
chain D (Fig. 3A and 3B). The DAPIR molecule is bound
at the RihA active site in two conformations, differing in
the orientation of the diaminophenyl group. The N3
amino group of DAPIR can either be directed towards the
α9 helix of RihA (as found in chain A, as per PDB file
nomenclature), or towards the αL loop (chains B and D).
These two conformations are related by a 180° rotation
about the C-C pseudo-glycosidic bond. In chain C, the
inhibitor is bound in both conformations, with approxi-
mately equal occupancy.
In agreement with the mode of binding of ribonucleo-
side analogues to group I NHs observed by X-ray crystal-
lography [16,24], the binding between DAPIR and the
calcium metal centre in RihA occurs through the 2' and
3'-hydroxyl groups of the ribose moiety, and is further
strengthened by hydrogen bonding of the hydroxyl group
in O5' to Asn158 and Glu164. The octacoordination of
the calcium ion involves the DAPIR 2' and 3'-hydroxyls,
the carboxylates of three Asp residues at positions 10, 15,
and 241, the Thr124 backbone oxygen, and a water mole-
cule (Fig. 3C). This ordered water molecule is hydrogen
bonded to both Asp10 and Asn166, and reveals the posi-
tion of the incoming nucleophile in the CU-NH-cata-
lyzed hydrolytic reaction.
The diaminophenyl ring of the inhibitor, mimicking the
nitrogenous base of substrates, establishes only van der
Waals' interactions with the side chains of Ala78, Val81,
Phe165, Phe223, and Lys228. No specific polar or hydro-
gen bonding interactions are formed between the amino
groups of DAPIR and RihA, regardless of the inhibitor
conformation. The further absence of the O2-carbonyl
that is present in the natural pyrimidine nucleoside sub-
strates may explain the dual binding mode of DAPIR at
the active site. The interaction with DAPIR induces dif-
ferent degrees of rearrangement of the catalytic pocket of
RihA. Indeed, in chains B and D, both the C-terminal
portion of the α9 helix and the αL loop remain flexible as
Figure 1 Ligands of the E. coli pyrimidine-preferring NH RihA. A) Uridine and B) cytidine, the natural substrates. C) The competitive inhibitor DA-
PIR. The iminoribitol moiety resembles the features of the transition state of the hydrolytic reaction, including a partial double bond character of the 
C1'-O4' bond, an elongated N-glycosidic bond, and a partial positive charge at the sugar ring.Garau et al. BMC Structural Biology 2010, 10:14
http://www.biomedcentral.com/1472-6807/10/14
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Figure 2 Crystal structure of RihA bound to DAPIR. A) The RihA monomer, with α-helices coloured brown, β-strands blue, and loop regions in cyan. 
The active site Ca2+ ion is shown as a yellow sphere, and the DAPIR molecule as sticks coloured according to atom type. B) The RihA tetramer, as ob-
served in the asymmetric unit of the RihA-DAPIR complex crystals.Garau et al. BMC Structural Biology 2010, 10:14
http://www.biomedcentral.com/1472-6807/10/14
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Figure 3 Structural features of the RihA-DAPIR complex. A) Superposition of the four crystallographically-independent molecules of RihA. The Cα 
trace of the four RihA monomers are shown in grey, and the αL (red) and α9 (green) segments are labelled for clarity. The four independent RihA chains 
are virtually undistinguishable. The αL loop is completely visible in chain A, while the full α9 helix could be traced only in chain D, as per nomenclature 
of the deposited coordinates. B) The DAPIR molecule bound to the active site of chain A superimposed with a (2mFo-DFc, ϕc) shake-omit electron 
density map contoured at 1.2σ. C) Octacoordination of the active site Ca2+ ion. Five oxygen atoms from RihA amino acid residues, the O2' and O3' 
hydroxyls of DAPIR, and an highly-ordered water molecule complete the coordination sphere of the metal.Garau et al. BMC Structural Biology 2010, 10:14
http://www.biomedcentral.com/1472-6807/10/14
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seen in the RihA-product complex (Fig. 3A). Conversely,
the inhibitor conformation observed in molecule A of the
RihA tetramer has a stabilizing effect on the protein con-
formation. In this polypeptide chain, residues Asn80-
Val81-His82-Gly83 assume a helical conformation (αL),
allowing the side chains of residues Val81 and His82 to
face the inner portion of the active site and interact with
the aromatic ring of DAPIR. Simultaneously, Val81
approaches also the C-terminal portion of the α9 helix,
promoting van der Waals' interactions with amino acids
Phe223 and His227. The closed conformation of the αL
and α9 segments is apparently attainable only when the
N3 amino group of DAPIR points towards the α9 helix. In
this conformation, residue Ala78 closely approaches the
C5 atom of the aminophenyl ring (3.8 Å). In the opposite
orientation, the N3 amino group prevents Ala78 to reach
the same conformation, and this likely destabilizes the αL
segmen t (F ig. 4A and 4B). In t he closed struct ur e, the
highly conserved His82 residue of the αL loop is interact-
ing via a hydrogen bond between its Nδ side chain atom
and the corresponding atom of His13, in a side-by-side
orientation. These interactions, together with the inter-
subunit interactions described previously, allow a partial
restructuring of helix α9 in a rotated and extended con-
formation. However, the terminal portion of the α9 helix
and subsequent loop are only defined in molecule C, and
this is likely due to crystal contacts established by this
subunit. Indeed, the RihA-ligand interactions are appar-
ently insufficient to induce the complete closure of the
active site above the bound ligand and the shielding of the
reaction centre from the bulk solvent, as previously
observed in the C. fasciculata IU-NH bound to the struc-
turally-related compound pAPIR [24].
The conformation of the iminoribitol moiety is charac-
terized by a C4'-endo puckering of the ring, similar to
that observed in other NH-ligand complexes [16,24,28].
This conformation is observed at low frequency in nucle-
osides and nucleotides in solution, where the C2'-endo or
C3'-endo structures are more common, and is a direct
consequence of the specific interactions between the
ribosyl hydroxyls and the active site Ca2+ ion. The orien-
tation of the inhibitor moiety mimicking the pyrimidine
base is roughly perpendicular to the iminoribitol ring, in
an axial conformation that is also disfavoured in solution
(Fig. 4A and 4B). Taken together, it is clear that the
enzyme-substrate contacts at the CU-NH active site
cooperate in stabilizing a high energy conformation of
the ligand. This finding confirms that the enzymatic
strategy by CU-NHs takes advantage of ground state
destabilization to reach the transition state geometry, as
demonstrated for the homologous IU-NHs.
R e s i d u e s  i n v o l v e d  i n  t h e  f o r m a t i o n  o f  h e l i x  α L  a r e
highly conserved in both IU- and CU-NH sequences,
suggesting that this secondary structure element is likely
a conserved feature in all CU-NH-substrate complexes.
Conversely, the number and nature of the residues at the
C-terminal portion of the α9 helix are highly variable
among group I members, and can thus assume helical
structures differing in length. Interestingly, strand β8 that
immediately follows the α9 helix and pairs with β7 is
present in CU-NHs so far characterized, but not in the
non-specific IU-NHs. The presence of strand β8 is asso-
ciated with the insertion of a glycine residue in position
236 (according to the RihA sequence numbering) and a
proline in position 238, and can thus have effects on the
mobility of helix α9.
Emerging principles of nitrogenous base specificity in CU-
NHs
RihA and RihB are two CU-NH enzymes from E. coli dis-
playing similar kinetic parameters for the steady state
hydrolysis of the pyrimidine nucleosides uridine and cyti-
dine. The structural comparison between the DAPIR-
bound RihA and the available RihB structures helps the
identification of the determinants for pyrimidine base
recognition. A superposition of the closed form of E. coli
RihA and RihB enzyme (rmsd = 1.4 Å for 304 Cα atoms of
subunit A) highlights both conserved features and
marked diversities at the active site. The residues of RihA
involved in the αL formation are similarly arranged in
RihB, as expected from their low variability in group I
NHs. The conservative substitution of a valine with an
isoleucine residue at position 81 in RihB maintains the
characteristics of the van der Waals' interaction with the
hydrophobic base of nucleosides, and does not affect sig-
nificantly the conformational restraints imposed on the
substrate. Thus, it is clear that the αL helix in group I
NHs performs a conserved role. In contrast, two major
differences are apparent when comparing the α9 helices
of the two enzymes. The presence or absence of two spe-
cific Tyr residues in this element determines the purine
versus pyrimidine nucleoside specificity in group I NHs
[16]. The helix α9 superimposes well in the structures of
RihA and RihB for the initial 15 residues (Gly210-Leu224
of RihA), but assumes a distinct orientation and exten-
sion of the protein backbone at its C-terminal region (Fig.
5A). In this region, the two enzymes have different num-
ber and type of residues, and do not show a clear homol-
ogy or conservation. Secondly, the only polar residues
positioned in the active site that can contribute to specific
hydrogen bonding interactions for ligand discrimination
are Lys228 in RihA, and Gln227 and Tyr231 in RihB. All
these amino acids reach inside the active site only when
helix α9 assumes the extended and ligand-stabilized
closed conformation. Thus, the two enterobacterial CU-
NHs clearly differ at important active site residues, yet
these differences do not compromise their ability to inter-
act and hydrolyze pyrimidine ribonucleosides.Garau et al. BMC Structural Biology 2010, 10:14
http://www.biomedcentral.com/1472-6807/10/14
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The structure of the complex RihA-DAPIR reported
here provides now a valid template for understanding the
interactions of uridine and cytidine in both RihA and
RihB, and helps clarifying the different catalytic efficien-
cies of the two enzymes for different pyrimidine sub-
strates. When modelling the complex of RihA with
uridine and cytidine, the charged His227 residue closely
approaches the substituent present at the 4 position of
the nitrogenous base (Fig. 5B). An acceptor group at this
position, such as the 4-carbonyl of uridine, can establish
favourable interactions with the charged lysine residue.
Conversely, the enamino group of cytidine primarily acts
as a hydrogen bond donor, and thus is disfavoured in the
interaction with His227 (Fig. 5B). Indeed, RihA shows
higher affinity for uridine than for cytidine (KM = 83 μM
and 524 μM, respectively), and this can be accounted for
by the different energetics of the interaction of the sub-
strates with His227. Moreover, it should be noted that
Lys228 may further rearrange in order to bring its side
chain into the active site upon binding of natural sub-
strates. This effect can also be appreciated when compar-
ing the pseudo second order rate constant kcat/KM,
indicative of the level of transition state stabilization in
Figure 4 Dual mode of DAPIR binding to RihA. A) Stereo view of the active site of molecule A, showing the closed αL segment with the inhibitor 
N3 group pointing towards helix α9. B) Stereo view of the active site of molecule B, where the αL segment is flexible and the N3 amino group of DAPIR 
points in the opposite direction compared to panel C.Garau et al. BMC Structural Biology 2010, 10:14
http://www.biomedcentral.com/1472-6807/10/14
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enzymatic reactions. Based on this parameter, RihA
attains a greater degree of stabilization for uridine than
cytidine (kcat/KM = 2 × 105 and 2 × 104 M-1s-1, respec-
tively) [19], hence suggesting that the interaction with
His227 may also contribute to the stabilization of the
negative charge developing at the uracil ring along the
reaction coordinate. Residue His240 is poised for proton
transfer to the leaving group, or to further polarize the
nitrogenous base via a hydrogen bond. In the RihB CU-
NH, the residue pair Gln227/Tyr231 is positioned in the
active site, and can establish polar interactions with the
nitrogenous base that can guide substrate discrimination.
RihB is similarly active with both uridine and cytidine
(kcat/KM ≈ 2 × 105 M-1s-1) [11], with a higher affinity for
uridine over cytidine (KM = 142 μM and 532 μM, respec-
tively) indicating again suboptimal binding interactions
between the cytidine enaminic group and residues
Gln227/Tyr231. However, while the RihA turnover num-
ber is similar for these two pyrimidinic substrates (kcat ≈
12 and 14 s-1), RihB hydrolyzes cytidine at a twofold faster
rate (kcat ≈ 12 vs. 5 s-1), indicating that in the presence of
cytidine the Gln227/Tyr231 pair allows a higher degree of
stabilization of the transition state, possibly by favouring
the orientation of the O2 carbonyl for proton transfer.
Taken together, these structural and kinetic data strongly
support the hypothesis that CU-NHs do not discriminate
different pyrimidine ribonucleosides during the substrate
binding event, but mainly through the stabilization of the
transition state of the enzymatic reaction. This finding
parallels the recent results demonstrating that CU-NHs
bind to purine nucleosides, but lack the crucial residues
for efficient leaving group activation [16]. The similarities
between the so far characterized CU-NHs RihA and RihB
also suggest that the catalytic power of the enzymes is
mediated by the conserved αL loop and the proton donor
His239, while helix α9 provides a fine tuning of the sub-
strate specificity through hydrogen bonding interactions.
Active site plasticity
We further analyzed the binding cavity of RihA to assess
whether it is tailored for the common RNA nucleosides,
or may display a broader substrate specificity. The molec-
ular surface of the active site does not show a tight com-
plementarity to the DAPIR molecule, in either
conformation (Fig. 6A and 6B). Indeed, the enzyme does
not fully wrap around the ligand, rather leaving empty
spaces on both sides of the ring. These unfilled cavities
may allow other nucleosides to act as substrates. Indeed,
substituents protruding from the C2, N3, and C4 posi-
tions could be accommodated in the binding site without
major structural rearrangements. Substituents at C5 are
likely restricted to methyl or similarly small groups, since
larger moieties would suffer from the steric hindrance of
Figure 5 A comparison of the structures of the pyrimidine-prefer-
ring CU-NHs RihA and RihB from E. coli. A) Superposition of the RihA 
and RihB monomers, shown as Cα traces. The α9 helix conformation 
differs significantly between the two proteins and is indicative of the 
plasticity of the flexible regions in NHs to adapt to different ligands. B) 
Model of interactions between RihA and uridine (top) or cytidine (bot-
tom).Garau et al. BMC Structural Biology 2010, 10:14
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residues Ala78 and Trp159, preventing the rearrange-
ment of the αL loop to the catalytically-relevant confor-
mation as observed in the present structure in chains B,
C, and D. The molecular surface of the enzyme clearly
shows that the binding cavity maintains open spaces, and
thus may accommodate substrates bearing a bulkier agly-
cone compared to pyrimidine bases such as uracil or cyti-
dine.
Catalytic cycles between the open and closed 
conformations of RihA
The availability of highly detailed structures of DAPIR
and ribose bound to the RihA CU-NH provide insights
into the dynamic enzyme rearrangements accompanying
N-glycosidic bond hydrolysis. One open question in NH
enzymology is how is the transition from the closed to
the open form of RihA triggered upon catalysis? Cleavage
Figure 6 Active site versatility of RihA. Molecular surfaces at the RihA active sites of two independent molecules. Two orthogonal views are shown, 
highlighting the existence of empty cavities that may accommodate different types of substrates. Panels A) and B) depict the surfaces of chain A and 
chain D, respectively.Garau et al. BMC Structural Biology 2010, 10:14
http://www.biomedcentral.com/1472-6807/10/14
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of the N-glycosidic bond of pyrimidine nucleosides
allows the relaxation of the constrained nucleoside struc-
ture observed in the RihA/DAPIR complex, and allows a
relocation of both the base and the ribose products. A
repositioning of the nitrogenous base, required to avoid
repulsive interactions with the ribose C1' atom, may dis-
rupt its contacts with the active site residues from both
αL and α9. As the base moves away from the side chain
atoms of Val81 and His82, the αL conformation will
become less stable, or could sample different conforma-
t i o n s  a s  d e m o n s t r a t e d  b y  t h e  u n l i g a n d e d  o r  p r o d u c t -
bound group I NH structures. This flexibility may lead to
the disruption of the hydrogen bond between His13 and
His82, allowing the side chain of the former amino acid to
protrude in the active site and preventing residue Phe223
to assume the conformation observed in the RihA-
DAPIR complex. When the αL is no more present in the
active site, also the van der Waals' contacts between
Val81 and Asp88 from αL, and Phe223 and His227 in
helix α9 cannot be established (Fig. 4A and 4B). Hence,
the α9 helix is destabilized in absence of the closed αL
segment and undergoes a rotation about its axis and a
swivelling movement towards the open conformation.
The lack of specific stabilizing contacts results in a high
flexibility of this segment, typically disordered in group I
NH structures determined by X-ray crystallography. The
side chain of Asn39 undergoes a minor rotation allowing
the ribose ring to move by about 0.5 Å towards the outer
portion of the active site, in a weakly bound conformation
that can be displaced by the bulk solvent. Thus, the con-
formational rearrangements occurring to αL and α9 upon
release of the nitrogenous base appear to be coupled,
since in the close conformation the two structural ele-
ments display strong reciprocal interactions, as well as
with the substrates. Further experiments to confirm this
cooperative motion are underway using mutagenesis and
molecular dynamics calculations. Given the importance
of these motions in regulating product release, the pres-
ent findings also raise the question as to whether the
steady-state kinetic parameters are affected by the
isomerization step, as seen for the group II IAG-NH from
Trypanosoma vivax [29].
Discussion
The work here reported provides the first description at
the atomic level of the interactions of a pyrimidine-spe-
cific NH enzyme with a competitive inhibitor that resem-
bles the natural substrates. The comparison between this
structure and the same enzyme bound to the reaction
product helped the definition of several aspects of the
enzymatic mechanism and dynamics in CU-NHs. More-
over, it provides insights into future developments for the
identification of NH substrates alternative to classical
RNA nucleosides.
The catalytic mechanism of group I NH enzymes, as
determined for the C. fasciculata IU-NH, proceeds
through an SN1-type transition state with an oxonium
ion-like geometry at the ribose ring [2,27]. In RihA, sub-
strate binding induces the active site closure, and the cor-
rect positioning of active site key residues for substrate
recognition. The calcium metal centre directs the binding
of the substrate molecule and its distortion to a high-
energy conformation, and may activate the coordinating
water molecule for nucleophilic attack. The involvement
of the Asp10 as general base in the mechanism has been
well documented [2,24]. After hydrolysis, the enzyme
active site opening leads to the base release and an acces-
sible active site. Comparing the substrate-bound and
ribose-bound RihA structures, three ordered water mole-
cules displace the nucleobase in the latter, thus support-
ing the hypothesis that the release of ribose in the final
step of the catalytic cycle requires its displacement by
bulk solvent molecules. The availability of the structures
of the product-bound and ligand-bound RihA enzyme
now allows the use of molecular dynamics simulations to
provide further insights into the conformational rear-
rangements taking place in the catalytic cycle of CU-
NHs.
The positions of amino acids His82, Lys228, and His240
are highly indicative of their active role in the stabiliza-
tion of the Michaelis complex. His240 is potentially
involved in the transfer of a proton to the pyrimidine car-
bonyl O2, since mutation of the homologous histidine in
RihB suggested indeed an essential role in leaving group
activation. Residues His227 and Lys228 likely assists in
the binding of nucleosides, establishing hydrogen bonds
with the nucleobase substituents that direct substrate dis-
crimination and may also participate in catalysis. In light
of the present structure, we can argue that the main role
of His82 is to act as (sensor) of the presence of a substrate
in the active site, and to initiate αL and α9 restructuring
after establishing a side-by-side H-bond connection with
His13. This interaction allows the relocation of the α9
helix residues by locking His13 in an orientation that
removes the side chain from the active site. The catalytic
activity of group I NHs shows a bell-shaped pH depen-
dency, involving two residues with pKa nearing neutral
for maximal activity. Based on the present results we
speculate that protonation state of His82 may affect the
kinetics of transition between the open and closed struc-
tures.
Ri h A  a n d  Ri h B  d i f f e r  i n  t h e  c o n f o rm a t i o n  o f  t h e  α 9
helix and at the amino acids believed to mediate substrate
specificity, yet their steady state kinetic parameters are
fairly similar. The DAPIR-RihA complex allowed us to
explain this apparent discrepancy disclosing that the
enterobacterial enzymes perform hydrolysis of ribonucle-
osides through a transition state that can be stabilized viaGarau et al. BMC Structural Biology 2010, 10:14
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substantially different interactions within the active site.
Structural models obtained using natural occurring sub-
strates support this hypothesis and suggest that substrate
discrimination occurs after the initial substrate binding
event, when the enzyme restructures to maximize bind-
ing interactions for catalysis. Instead, the chemical step is
carried out with similar efficiency by the conserved resi-
dues at the active site. In turn, this implies that the steady
state rate constant for pyrimidine nucleoside hydrolysis
may be significantly affected by the kinetics of the open-
closed transition in the enzyme. The functional implica-
tion of these findings is that the two CU-NH enzymes
from E. coli can both guarantee efficacy of catalysis for
different substrates. Moreover, the presence of two dis-
tinct enzymes with different ability of interaction and
active site flexibility might assure a wide versatility in
substrate recognition.
The preference of RihA for uridine is consistent with
the fact that in the pyrimidine salvage pathway of E. coli
cytidine is efficiently converted to uridine by cytidine
deaminases, a family of enzymes that has been discovered
with the ability to deaminate cytidines also directly on
RNA[30,31]. However, the recycling of uridine and cyti-
dine in E. coli is normally promoted by reversible nucleo-
side phosphorylases, hence the activity of RihA and RihB
is likely directed also towards alternative N-ribosides.
They might act on common nucleosides under yet
unidentified physiological conditions, or alternatively
preferentially act on modified nucleosides found in RNA
molecules. The present structure demonstrates that RihA
is endowed with a significant active site flexibility, as
demonstrated by the dual binding mode of DAPIR and
the different conformations attainable by the enzyme,
and thus may also act on modified nucleosides. Among
these, pseudouridine (ψ) contains a C-glycosidic bond,
and is thus not a potential substrate of CU-NHs. Um and
Cm are rare nucleotides with methyl groups at the O2'
position, and are also likely not substrates for NHs since
this modification would disrupt the crucial interaction
with the active site Ca2+ ion that is necessary for substrate
binding and distortion. On the contrary, molecular mod-
elling analysis suggests that the common bacterial base-
modified methyl-containing (m3C, m5C, m5U), sulphur-
containing (s2U, s4U), and also rare Se2U and D nucleo-
sides, are all able to fit the active site of RihA and RihB,
and thus raising the possibility that potential substrates of
CU-NHs could likely belong to this group of RNA modi-
fications, which are essential for normal cell growth.
Interesting, methylations of RNA affect in particular
unusual base-pairing interactions of ribosomes, and their
accumulation in bacteria is often indicative of emerging
antibiotic resistance [32]. Thiopyrimidine analogues and
seleniumuridine are present at specific positions in spe-
cific tRNA molecules, and are involved in unusual activi-
ties such as a bacterial photosensor or thermosensor [13].
In addition, the processes following thiouridine excita-
tion by UV-A light are related to deleterious effects
induced in living systems. Thus, resistance to exogenous
compounds, ambient sensitivity, and detoxification from
harmful pyrimidines, appear conditions where the hydro-
lytic function of bacterial CU-NHs might operate. We
expect that further studies on the activity of these
enzymes may eventually confirm their involvement in the
turnover of modified nucleobases deriving from the
breakdown of RNA molecules.
Conclusions
The structure of RihA with the inhibitor DAPIR
describes the enzyme structural rearrangement and
interactions when bound to an active site ligand, under-
scores a buttressing role of the tetrameric assembly, and
provides a snapshot of a structure sampled along the
reaction coordinate. A comparison with the ribose-
bound form reveals that the presence of the nitrogenous
base is required for the enzyme active site closure. The
flexible loops in the αL and α9 regions of group I NHs can
assume different conformation to adapt to the active site
ligand properties. The conserved His82 residue of group I
NHs aids the restructuring of the active site through
interaction both with the substrate and protein residues.
The similar catalytic efficiencies of the two enterobacte-
rial CU-NHs may reflect a rate-limiting role in catalysis
of the observed conformational changes.
Methods
Protein cloning, expression and purification
The  rihA  gene (936 bp) was amplified from E. coli
genomic DNA extracted from the K12 derivative DH5α
strain. The gene was amplified by PCR using the forward
primer  rihA-NdeI (TACGTGCATATGGCACTGCCA-
ATT) and reverse rihA-BglI (GGGCAGATCTT-
TAAGCGTAAAATTTCAG), designed to add the NdeI
restriction site at the 5' end of the gene, and the BglI site
after the stop codon. Amplification was performed with
the Deep Vent DNA Polymerase (New England Biolabs)
in the presence of 0.2% DMSO to improve DNA denatur-
ation. The gene was cloned via blunt end ligation in the
pBluescript II SK (-) vector (Stratagene) previously
treated with SmaI, and sequenced on both DNA strands
using the automated dideoxy method. The pBSK-rihA
plasmid was treated with the restriction endonucleases
NdeI and BglI, the fragment containing the rihA gene was
purified from 1% agarose gel, and ligated between the
corresponding sites of the pET-28b(+) vector (Novagen).
A liquid LB overnight culture of BL21(DE3) E. coli cells
transformed with the pET28-rihA was diluted 1:100 in LB
medium containing 1% glucose and 50 μg/ml kanamy-
cine. Expression was induced at a culture optical densityGarau et al. BMC Structural Biology 2010, 10:14
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at 600 nm of 0.6 by addition of 0.5 mM IPTG for 3 h at
37°C under vigorous shaking. Cells were harvested by
centrifugation, resuspended in a buffer containing 20
mM Tris pH 8, 50 mM NaCl, and the Complete EDTA-
free mixture of protease inhibitors (Roche), and disrupted
by sonication. The RihA protein in the soluble fraction
was bound to a NiNTA resin (Qiagen) and eluted using a
buffer containing 100 mM Tris pH 8, 500 mM NaCl and
500 mM imidazole. The enzyme was further purified
using size exclusion chromatography on a Superdex 200
column using an isocratic elution with 50 mM Hepes pH
7.2, and 150 mM NaCl. The N-terminal hexahistidine
peptide was removed by partial proteolysis using throm-
bin at a ratio of 1:500 w/w, and the protein further puri-
fied using size exclusion chromatography.
Inhibition studies
The inhibition constant of DAPIR was measured compar-
ing the initial rate of the RihA-catalyzed hydrolysis of uri-
dine in the presence or absence of inhibitor. Reaction
were carried out in Hepes buffer pH 7.4, 100 mM NaCl
and 80 μM uridine. Progress curves were recorded on a
UltroSpec2100 spectrophotometer (GE Healthcare) at
37°C with a wavelength of 262 nm (Δε = -2.18 μM-1·s-1).
Initial velocities were measured in the presence of differ-
ent concentrations of inhibitor, and the inhibition con-
stant was derived from the equation v0/vI = (KM(1 + [I]/
KI) + [S])/(KM + [S]), where v0 and vI are the initial rates
in the absence and presence of inhibitor, respectively.
This equation assumes competitive inhibition, and this is
supported by the structural resemblance of DAPIR to the
natural substrates and the observed binding at the active
site residues.
Crystallization and data collection
A 8 mg·ml-1 RihA solution in 50 mM Hepes pH 7.2, 150
mM NaCl was mixed with a 5:1 molar excess of DAPIR
solubilized in 50 mM Hepes pH 7.2, and incubated at 4°C
for 3 hours. Crystals of the RihA-DAPIR complex were
obtained by hanging drop vapour diffusion at 20°C. The
protein/inhibitor complex was mixed with equal volumes
of a precipitant solution containing 25% PEG 4000, 0.1 M
sodium acetate pH 5.0. Crystals were visible within three
days, and grew to maximum dimensions of 300 × 150 ×
150 μm. For data collection, a single crystal was mounted
in a nylon-fiber loop and flash-cooled in a dry nitrogen
stream at 100 K. A buffer with the PEG concentration
increased to 34% was used as cryoprotectant. Diffraction
data to 2.05 Å were collected at the beamline ID14-EH1
of the European Synchrotron Radiation Facility (Greno-
ble, France) on a Quantum4 CCD detector using the
oscillation method and an X-ray wavelength of 0.933 Å.
Data were indexed, integrated, and scaled using the pro-
gram XDS [33], and the measured intensities were con-
verted to structure factor amplitudes using the program
TRUNCATE [34], part of the CCP4 suite [35]. The crys-
tals belong to the monoclinic P21 space group, as judged
from systematic absences, with unit cell dimensions a =
84.36 Å, b = 82.99 Å, c = 94.00 Å, β = 112.1°. The cell vol-
ume is consistent with four RihA monomers in the asym-
metric unit, with 44% solvent and a Matthews' coefficient
of 2.3 Å3/Da.
Structure solution and refinement
The structure of RihA was solved using the molecular
replacement technique as implemented in the program
MOLREP [36] using the monomer of the RihA from the
YbeK/ribose complex structure (PDB code 1YOE) as the
search model after removal of all solvent molecules,
ligands, and ions. A single conformation was chosen for
the residues that displayed multiple rotamers in the
RihA-ribose complex structure. Rotation and translation
functions calculated using data to 4.0 Å resolution
yielded four unambiguous, distinct solutions in space
group P21 but not in space group P2, confirming the ini-
tial assignment. An initial electron density map was cal-
culated with |2Fo-Fc| coefficients and model phases using
data to 2.1 Å resolution. This map showed the presence of
the catalytic Ca2+ ions, and indicated that one DAPIR
molecule was bound at each active site. Manual rebuild-
ing in sigmaA-weighted (2mFo-DFc,  ϕc) and (mFo-DFc,
ϕc) electron density maps using the program COOT [37]
and restrained maximum-likelihood positional and iso-
tropic temperature factor refinement with REFMAC5
[38] were performed in a cyclic process to gradually
improve the model. After the R-factor decreased below
0.30, water molecules were added to the model by visual
inspection in positive peaks >3σ of difference maps.
Anisotropic motions were modelled through refinement
of the torsion, libration, and screw axis tensors (TLS),
treating each independent polypeptide in the asymmetric
unit as an independent group. The final crystallographic
Rcrys and Rfree values converged to 0.20 and 0.24, respec-
tively. The geometry of the model was monitored during
r e f i n e m e n t  w i t h  P R O C H E C K  [ 3 9 ]  a n d  M O L P R O -
BITY[40]. Molecular superpositions were carried out
with the program LSQMAN[41]. Figures and schemes
were generated using PYMOL http://www.pymol.org and
IsisDraw. The coordinates and structure factors of the
RihA-DAPIR complex have been deposited with the PDB
http://www.rcsb.org/pdb with accession code 3G5I.
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